SpaceX spacecraft returns to Earth, sends sonic boom across Southern California
Did a loud boom startle you or your neighbors' dogs on Saturday night in Southern California? If so, you're not alone.
SpaceX announced that its spacecraft, Dragon, reentered Earth's atmosphere and 'splashed down' off the southern coast near Oceanside around 10:44 p.m.
'Dragon will also announce its arrival with a brief sonic boom prior to splashing down in the Pacific Ocean,' stated SpaceX in an X post.
SpaceX's website said the Dragon is 'the only spacecraft currently flying that is capable of returning significant amounts of cargo to Earth, and is the first private spacecraft to take humans to the space station.'
A report by NASA explained that the unpiloted Dragon spacecraft was launched aboard a Falcon 9 rocket that took off from NASA's Kennedy Space Center in Florida on April 21.
Landing on April 22, it delivered about 6,700 pounds of crew supplies, science investigations and equipment to the International Space Station, NASA reported.
Then, on Friday, May 23, ground controllers at SpaceX commanded the Dragon spacecraft to undock from the port of the station's Harmony module to begin its return to Earth.
SpaceX confirmed Dragon's 'splashdown' in a 10:46 p.m. X post, saying it completed the company's SpaceX's 32nd Commercial Resupply Services mission to the Space Station.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
37 minutes ago
- Yahoo
Sen. Rick Scott urges Trump to relocate NASA headquarters to Florida
On Tuesday, Senator Rick Scott made a pitch to relocate NASA Headquarters from D.C. to Florida's Space Coast. He sent this letter, signed by the entire Florida Delegation, to the Trump Administration asking the President to consider the move. But this afternoon, NASA Watch Founder Keith Cowing told me it's unlikely. He told us, 'I've read the letter, and everybody signed it. Who's a Republican from Florida. They want to move with the Florida because a lot of space people work there. That are isolated from the political environment in DC. Okay, well, you have a big political environment down there. So, I own the lobbyists. Well, they'll just set up new offices. It'll take years.' In his letter, said the lease on Headquarters is expiring, and there's a 500-million plan for a new facility in the National Capitol Region. Scott says Space Florida has build to suit options. He called the state the undisputed leader in space operations and talked about leveraging a world-class workforce. Dr. Don Platt, an Associate Professor of Space Systems at Florida Tech said, 'We do have to remember that the people that work in NASA headquarters are people that interface with Capitol Hill. They interface with budgets, national space policy. They do not build rocket engines. They do not program software. Not engineers, they're more likely to be someone with a business background or a master's in management or finance or any of those areas.' Platt also said that if the Trump administration really was contemplating an HQ move for NASA, several states would be vying for that prize. Scott's letter follows the introduction of the CAPE Canaveral Act earlier this year. Scott co-sponsored the bill, which calls for the relocation of NASA headquarters from D.C. to Brevard County. Click here to download our free news, weather and smart TV apps. And click here to stream Channel 9 Eyewitness News live.
Washington Post
an hour ago
- Washington Post
Kennedy's new CDC panel includes members who have criticized vaccines and spread misinformation
NEW YORK — U.S. Health Secretary Robert F. Kennedy Jr. on Wednesday named eight new vaccine policy advisers to replace the panel that he abruptly dismissed earlier this week . They include a scientist who researched mRNA vaccine technology and became a conservative darling for his criticisms of COVID-19 vaccines, a leading critic of pandemic-era lockdowns, and a professor of operations management.
Fast Company
an hour ago
- Fast Company
Enough hype about AI in health—let's talk about results
There's no shortage of big promises about AI in healthcare. The U.S. government announced a $500 billion Stargate initiative to fund AI infrastructure, while the UK government announced £82.6 million in research funding for three projects, two of which are using AI to tackle cancer and Alzheimer's disease. But ask any patient waiting for a diagnosis, or a clinician searching for certainty, and the real question cuts through all the noise: When will all the innovation deliver real impact where it matters most? We've entered an era where healthcare data is measured in exabytes—genomes, images, clinical notes, labs, and signals from every continent. At SOPHiA GENETICS, we've just achieved the milestone of analyzing 2 million patient profiles. It's a number that was unimaginable a decade ago. Yet the value of data isn't in volume. It's what you do with it. Insight matters only if it changes an outcome, shortens a diagnostic odyssey, or opens up a new chance for a patient. It's time to move from conversation to action. Too often, insights get trapped in institutional silos or left in endless pilot projects, just out of reach of the people who need them. 3 ways AI is already transforming medicine Today, technology can connect, for example, a patient in São Paulo with expertise in Seoul, uncovering patterns invisible to the human eye. Here are several ways AI is helping now. 1. Improving diagnostic accuracy: AI algorithms, particularly those based on deep learning, have demonstrated remarkable accuracy in diagnosing diseases from medical images and test results. These systems are trained on vast datasets, allowing them to recognize patterns and anomalies that might be missed by the human eye. For example, in dermatology, AI systems trained on images of skin lesions have shown the ability to detect skin cancers, such as melanoma, with high levels of precision. 2. Enhancing cancer prevention: AI techniques can be used to screen individuals for genomic markers and develop personalized cancer risk prediction scores. This proactive approach can help screen younger patients for genomic predispositions, empowering them to make informed prevention decisions and proactively monitor their health. 3. Tailoring treatments to genomic profiles: One of the most significant applications of AI is in the field of genomics. AI can analyze vast genomic datasets to identify mutations and variations that might influence an individual's response to certain treatments. For example, our SOPHiA DDM product can identify specific genomic markers that are susceptible to targeted cancer therapies, increasing the efficacy of the treatment and minimizing the risk of adverse reactions, for a more effective and safer treatment plan for patients. To scale up these AI applications there are many regulatory and compliance barriers to overcome. This requires investment in data security, creating clear guidelines, data security measures, and ensuring clinicians are fully trained. Our goal should be to create a regulatory environment that fosters innovation while safeguarding patient data and promoting public trust. We must democratize this powerful data to enable more physicians, practices, and hospitals to incorporate AI into daily clinical use so that a greater number of patients can access data-driven medicine, not just a select few. My message for governments investing in AI is clear: Balance investing in future AI tools with validating existing solutions that have already been proven to improve patient outcomes. Build the bridges that turn breakthroughs into benefits, so that data-driven medicine becomes a reality for every patient.
